IP Library Granted Patent US 12,685,550
Granted Patent B2
US 12,685,550 · App. 18/403,951 · Granted Jul 21, 2026

Shock wave device

Inventors: Jiri Dasek (Soprec u Prelouce, CZ); Tomas Schwarz (Prague, CZ)
Assignee: BTL Medical Solutions a.s.
A61B17/2251A61N7/00B06B1/0644G10K9/122G10K11/02G10K11/30G10K15/043A61B2017/22027A61B17/225A61B2018/00994A61B18/12A61N2007/0056A61N2007/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,685,550
App. No.
18/403,951
Filed
Jan 4, 2024
Granted
Jul 21, 2026
Kind
B2
Art Unit
3798
USPC
601/4
Abstract

A device for shock wave production to treat a patient's body comprises a base with a condenser as power supply, an applicator having a pad, at least one piezo-element configured to generate a shock wave in response to a pulse of electric current having a pulse width, an acoustic lens configured to focus the shock wave, and a coil configured to increase the pulse width of the pulse of electric current.

Claims (49)

1 . A device for shock wave production to treat urological problems of a patient's body, comprising:

a condenser and a switch configured to discharge a pulse of electric current; and

an applicator configured to be coupled to the condenser and the switch and configured to provide a shock wave pulse to the patient's body, the applicator comprising:

an applicator cell comprising a cavity;

a single piezo-element attached to the applicator cell at a bottom of the cavity configured to generate the shock wave pulse in response to the pulse of electric current;

a dielectric material positioned in the cavity, fixing the single piezo-element in the cavity; and

an acoustic lens attached to the applicator cell below the single piezo-element configured to focus the shock wave pulse into the patient's body to provide pressure to the patient's body to treat the urological problems of the patient's body;

wherein the single piezo-element has a volume in a range of 1.5 cm 3 to 600 cm 3 .

2 . The device according to claim 1 , wherein a repetition frequency of delivery of the shock wave pulse is in a range of 1 Hz to 40 Hz.

3 . The device according to claim 1 , wherein the device further comprises at least one coil forming a circuit with the condenser and the switch, the at least one coil having an inductance in a range of 1 μH to 6 mH.

4 . The device according to claim 3 , wherein the at least one coil comprises a plurality of coils; and wherein the applicator is configured such that individual coils from the plurality of coils may be connected or disconnected in the circuit.

5 . The device according to claim 1 , wherein the acoustic lens has a radius of curvature in a range of 30 mm to 350 mm, and wherein the shock wave is configured to have a depth of focus volume at a vertical maximum focal volume cross section in a range of 0.1 mm to 100 mm.

6 . The device according to claim 1 , wherein the dielectric material has a flexural strength in a range of 10 MN·m −2 to 500 MN·m −2 .

7 . The device according to claim 1 , wherein the dielectric material has a tensile strength in a range of 10 MN m −2 to 300 MN·m −2 .

8 . The device according to claim 1 , wherein the dielectric material has an acoustic impedance in a range of 0.9·10 6 kg·m −2 ·s −1 to 6·10 6 kg·m −2 ·s −1 .

9 . The device according to claim 1 , wherein the least one shock wave pulse has a duration in a range of 200 ns to 30 μs.

10 . A device for shock wave production to treat urological problems of a patient's body, comprising:

a base comprising a condenser and a switch configured to discharge a pulse of electric current;

an applicator configured to be coupled to the base, the applicator comprising:

an applicator cell comprising a cavity, an inside of the cavity comprising:

a single piezo-element attached to the applicator cell at a bottom of the cavity;

a conductive plate attached to the single piezo-element;

a coil configured to be electrically connected in series with the conductive plate and the switch; and

a quantity of dielectric material positioned in the cavity, configured to fix and to protect the single piezo-element inside the cavity;

wherein the single piezo-element is configured to provide a shock wave in response to the pulse of electric current passing through the coil to the conductive plate based on a piezoelectric effect; and

an acoustic lens attached to the applicator cell below the single piezo-element and configured to focus the shock wave pulse into the patient's body;

wherein the shock wave is configured to deliver a pressure in a range of 5 MPa to 250 MPa to the patient's body to treat the urological problems of the patient's body.

11 . The device according to claim 10 , wherein the pulse of electric current has a voltage in a range of 2 kV to 50 kV.

12 . The device according to claim 10 , wherein the pulse of electric current passing through the coil is in a range of 10 A to 1 kA.

13 . The device according to claim 10 , wherein the acoustic lens has a radius of curvature in a range of 30 mm to 350 mm.

14 . The device according to claim 10 , wherein the dielectric material has an acoustic impedance in a range of 0.9·10 6 kg·m −2 ·s −1 to 6·10 6 kg·m −2 ·s −1 ; and wherein the acoustic lens has an acoustic impedance in a range of 10·10 6 kg·m −2 ·s −1 to 46·10 6 kg·m −2 ·s −1 .

15 . The device according to claim 10 , configured to produce first and second shock waves generated by one excitation electric pulse; and wherein a maximal pressure value of the second shock wave is greater than a maximal pressure value of the first shock wave.

16 . A method of treatment of urological problems of a patient's body, comprising:

coupling an applicator to a condenser and a switch configured to discharge a high voltage pulse of electric current;

positioning the applicator adjacent to a tissue of a patient, the applicator comprising:

an applicator cell comprising a cavity;

a coil inside the cavity configured to be electrically coupled to the condenser and the switch on an input of the coil;

a single piezo-element inside the cavity attached to the applicator cell at the bottom of the cavity;

a conductive plate inside the cavity, coupled to the single piezo-element and electrically connected to an output of the coil;

a quantity of dielectric material positioned in the cavity, configured to fix and increase durability of the single piezo-element inside the cavity; and

an acoustic lens configured to be attached to the applicator cell below the single piezo-element;

discharging the high voltage pulse of electric current through the coil to the conductive plate;

redistributing the high voltage pulse of electric current across the single piezo-element via the conductive plate;

generating a shock wave with the single piezo-element in response to the high voltage pulse of the electric current; and

focusing the shock wave pulse into the patient's body with the acoustic lens, such that a pressure delivered to treat the urological problems of the patient's body is in a range of 5 MPa to 250 MPa.

17 . The method according to claim 16 , wherein the high voltage pulse of electric current has a full width at half maximum in a range of 0.05 μs to 30 μs.

18 . The method according to claim 16 , wherein the energy of the shock wave in at least part of the focus volume is in a range of 0.01 mJ·mm −2 to 20 mJ·mm −2 .

19 . The method according to claim 16 , wherein the single piezo-element has a diameter in a range of 1 cm to 20 cm.

20 . The method according to claim 16 , wherein the dielectric material has a dielectric constant in a range of 1.0005 to 2000 and dielectric strength in a range of 1 kV·mm −1 to 90 kV·mm −1 .

Continuity (3)
Continuation 16205401 · Nov 30, 2018
Provisional Application 62592464 · Nov 30, 2017
Related Publication 20240225677A1 · Jul 11, 2024
References Cited (93)
US 4721874A · Emmert · 1988 [cited by applicant]
US 4858597A · Kurtze · 1989 [cited by applicant]
US 5076277A · Iwama · 1991 [cited by applicant]
US 5387190A · Gotanda · 1995 [cited by applicant]
US 5501655A · Rolt · 1996 [cited by applicant]
US 5545124A · Krause · 1996 [cited by applicant]
US 5873845A · Cline · 1999 [cited by applicant]
US 6036661A · Schwarze · 2000 [cited by applicant]
US 6113559A · Klopotek · 2000 [cited by applicant]
US 6325769B1 · Klopotek · 2001 [cited by applicant]
US 6368292B1 · Ogden · 2002 [cited by applicant]
US 6416478B1 · Hossack · 2002 [cited by applicant]
US 6736784B1 · Menne · 2004 [cited by applicant]
US 6755796B2 · Spector · 2004 [cited by applicant]
US 7189209B1 · Ogden · 2007 [cited by applicant]
US 8568339B2 · Rybyanets · 2013 [cited by applicant]
US 10743838B2 · Freiburg · 2020 [cited by applicant]
US 20020193709A1 · Bolze · 2002 [cited by applicant]
US 20040010211A1 · Spector · 2004 [cited by applicant]
US 20040015107A1 · Du · 2004 [cited by applicant]
US 20040036555A1 · Fehre · 2004 [cited by applicant]
US 20040167445A1 · Simnacher · 2004 [cited by applicant]
US 20050010140A1 · Forssmann · 2005 [cited by applicant]
US 20050015023A1 · Ein-Gal · 2005 [cited by applicant]
US 20050148911A1 · Talish · 2005 [cited by applicant]
US 20050154431A1 · Quistgaard · 2005 [cited by applicant]
US 20050192556A1 · Soltani · 2005 [cited by applicant]
US 20060100550A1 · Schultheiss · 2006 [cited by applicant]
US 20080146971A1 · Uebelacker · 2008 [cited by applicant]
US 20090088670A1 · Warlick · 2009 [cited by applicant]
US 20090156894A1 · Hagelauer · 2009 [cited by applicant]
US 20090171252A1 · Bockenstedt · 2009 [cited by applicant]
US 20110066084A1 · Desilets · 2011 [cited by applicant]
US 20110270139A1 · Bauer · 2011 [cited by applicant]
US 20120029393A1 · Lee · 2012 [cited by applicant]
US 20120157888A1 · Grob · 2012 [cited by applicant]
US 20130046210A1 · Zhong · 2013 [cited by applicant]
US 20130096436A1 · Little · 2013 [cited by applicant]
US 20130197404A1 · Spector · 2013 [cited by applicant]
US 20130294203A1 · Goodman · 2013 [cited by applicant]
US 20140024974A1 · Slayton · 2014 [cited by applicant]
US 20150005638A1 · Slayton · 2015 [cited by applicant]
US 20150177197A1 · Kojima · 2015 [cited by applicant]
US 20150224345A1 · Warlick · 2015 [cited by applicant]
US 20160001097A1 · Cho · 2016 [cited by applicant]
US 20170043189A1 · Stoddard · 2017 [cited by applicant]
US 20190060675A1 · Krone · 2019 [cited by applicant]
US 20200206072A1 · Capelli · 2020 [cited by applicant]
CN 201664476 · 2010 [cited by applicant]
CN 203598376 · 2014 [cited by applicant]
CN 205054800 · 2016 [cited by applicant]
DE 19949426 · 2001 [cited by applicant]
DE 102007014245 · 2008 [cited by applicant]
DE 202009011534 · 2010 [cited by applicant]
DE 202010014057 · 2011 [cited by applicant]
EP 0629993 · 1994 [cited by applicant]
EP 1072226 · 2001 [cited by applicant]
EP 1195167 · 2002 [cited by applicant]
EP 1863569 · 2007 [cited by applicant]
EP 1943998 · 2008 [cited by applicant]
EP 2166963 · 2010 [cited by applicant]
EP 2172159 · 2010 [cited by applicant]
EP 2308397 · 2011 [cited by applicant]
EP 2351530 · 2011 [cited by applicant]
EP 2382924 · 2011 [cited by applicant]
EP 2493434 · 2012 [cited by applicant]
EP 2628456 · 2013 [cited by applicant]
EP 3064157 · 2016 [cited by applicant]
EP 3154633 · 2017 [cited by applicant]
EP 3196221 · 2017 [cited by applicant]
JP 2011188924 · 2011 [cited by applicant]
JP 5557800 · 2014 [cited by applicant]
JP 5975600 · 2016 [cited by applicant]
KR 20080040111 · 2008 [cited by applicant]
KR 101418356 · 2014 [cited by applicant]
KR 101602820 · 2016 [cited by applicant]
KR 101747817 · 2017 [cited by applicant]
TW 201420213 · 2014 [cited by applicant]
WO 2007108854 · 2007 [cited by applicant]
WO 2009018406 · 2009 [cited by applicant]
WO 2011138784 · 2011 [cited by applicant]
WO 2013068569 · 2013 [cited by applicant]
C600, Operator Manual, 35 p., 2019. [cited by applicant]
Chattanooga—Moving Rehabilitation Forward, Focus Shockwave Operating Manual, 100 p., 2016. [cited by applicant]
Office Action (Final Rejection) dated Aug. 17, 2022 for U.S. Appl. No. 16/205,401 (pp. 1-30). [cited by applicant]
Office Action (Non-Final Rejection) dated Feb. 1, 2023 for U.S. Appl. No. 16/205,401 (pp. 1-31). [cited by applicant]
Office Action (Notice of Allowance and Fees Due (PTOL-85)) dated Aug. 30, 2023 for U.S. Appl. No. 16/205,401 (pp. 1-8). [cited by applicant]
Schmitz, et al., “Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database”, British Medical Bulletin vol. 116, Nov. 2015, pp. 115-1… [cited by applicant]
Storz Medical, Comparison of Shock Wave Technologies, 4 p., 2013. [cited by applicant]
Storz Medical, Duolith SD1 Application Brochure, 36 p., 2010. [cited by applicant]
Storz Medical, Duolith SD1 T-Top, 8 p., 2015. [cited by applicant]
Storz Medical, Duolith SD1, 16 p., 2005. [cited by applicant]
Storz Medical, Extracorporeal Shock Wave Therapy, 32 p., 2015. [cited by applicant]